Robert W. Hoffman

5.1k total citations · 1 hit paper
92 papers, 3.8k citations indexed

About

Robert W. Hoffman is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert W. Hoffman has authored 92 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Rheumatology, 52 papers in Immunology and 32 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert W. Hoffman's work include Systemic Lupus Erythematosus Research (50 papers), T-cell and B-cell Immunology (35 papers) and Monoclonal and Polyclonal Antibodies Research (30 papers). Robert W. Hoffman is often cited by papers focused on Systemic Lupus Erythematosus Research (50 papers), T-cell and B-cell Immunology (35 papers) and Monoclonal and Polyclonal Antibodies Research (30 papers). Robert W. Hoffman collaborates with scholars based in United States, United Kingdom and Germany. Robert W. Hoffman's co-authors include Eric L. Greidinger, Gordon C. Sharp, Pilar Pérez, David M. Segal, Jeffrey A. Bluestone, Stephen Shaw, Jane C. Johnson, Susan L. Deutscher, Sara E. Walker and Michelle Petri and has published in prestigious journals such as Nature, The Lancet and The Journal of Experimental Medicine.

In The Last Decade

Robert W. Hoffman

90 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial

2018 356 citations Daniel J. Wallace, Yoshiya Tanaka et al. profile →

Peers

Countries citing papers authored by Robert W. Hoffman

Since Specialization

Citations

This map shows the geographic impact of Robert W. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Hoffman more than expected).

Fields of papers citing papers by Robert W. Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Hoffman. The network helps show where Robert W. Hoffman may publish in the future.

Co-authorship network of co-authors of Robert W. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Hoffman. A scholar is included among the top collaborators of Robert W. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Hoffman. Robert W. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	POS1130 DESIGNING OF A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN INHIBITOR, IN ADULTS WITH PRIMARY SJÖGREN'S SYNDROME 2023 ·Annals of the Rheumatic Diseases ·Jesse J. Hubbard, Kim Campbell, Kathy L. Sivils, Robert W. Hoffman, Kim Hung Lo, Jocelyn H. Leu, Simon Bowman, Stephanie M. Liva, Qing Zuraw, Anne M. Stevens, Lei Ling, (unknown), Sindhu Ramchandren, Hui Sun, R. Hal Scofield, Raphaèle Séror, Daniel J. Wallace	1
2	OP0045 DELINEATION OF A PROINFLAMMATORY CYTOKINE PROFILE TARGETED BY JAK1/2 INHIBITION USING BARICITINIB IN A PHASE 2 SLE TRIAL 2020 ·Annals of the Rheumatic Diseases ·Thomas Dörner, Yoshiya Tanaka, Michelle Petri, Josef S Smolen, DJ Wallace, Byron Crowe, Ernst R. Dow, Richard E. Higgs, Guilherme Rocha, Robert J. Benschop, (unknown), Stephanie de Bono, Robert W. Hoffman, Damiano Fantini	1
3	A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus 2019 ·PLoS ONE ·Yupeng Li, Richard E. Higgs, Robert W. Hoffman, Ernst R. Dow, Xiong Liu, Michelle Petri, Daniel J. Wallace, Thomas Dörner, Brian J. Eastwood, Bradley B. Miller, Yushi Liu	12
4	IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis 2012 ·Journal of Allergy and Clinical Immunology ·James G. Krueger, Scott Fretzin, Mayte Suárez‐Fariñas, Patrick Haslett, Krista M Phipps, Gregory S. Cameron, Juliet McColm, (unknown), Inna Cueto, (unknown), Subhashis Banerjee, Robert W. Hoffman	300
5	T cell vaccination therapy in an induced model of anti-RNP autoimmune glomerulonephritis 2010 ·Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), Irina Fernández, Laisel Martinez, Robert W. Hoffman, Eric L. Greidinger	7
6	Immune pathogenesis of Mixed Connective Tissue Disease: A short analytical review 2008 ·Clinical Immunology ·Robert W. Hoffman, Marcos E. Maldonado	41
7	Differential tissue targeting of autoimmunity manifestations by Autoantigen‐Associated Y RNAs 2007 ·Arthritis & Rheumatism ·Eric L. Greidinger, (unknown), Laisel Martinez, Kimberly Jaimes, Mehdi Nassiri, P.A. Bejarano, Glen N. Barber, Robert W. Hoffman	19
8	A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen 2006 ·Arthritis & Rheumatism ·Eric L. Greidinger, (unknown), Kimberly Jaimes, (unknown), Mehdi Nassiri, P.A. Bejarano, Glen N. Barber, Robert W. Hoffman	50
9	A Major B Cell Epitope Present on the Apoptotic but Not the Intact Form of the U1-70-kDa Ribonucleoprotein Autoantigen 2004 ·The Journal of Immunology ·Eric L. Greidinger, Mark F. Foecking, Joseph Magee, L.A. Wilson, (unknown), Robert Ortmann, Robert W. Hoffman	31
10	Cloned Human TCR from Patients with Autoimmune Disease Can Respond to Two Structurally Distinct Autoantigens 2004 ·The Journal of Immunology ·(unknown), Senthil R. Kumar, Eric L. Greidinger, Robert W. Hoffman	10
11	Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production 2004 ·Arthritis & Rheumatism ·Eric L. Greidinger, Tal Gazitt, Kimberly Jaimes, Robert W. Hoffman	28
12	U1 RNA induces innate immunity signaling 2004 ·Arthritis & Rheumatism ·Robert W. Hoffman, Tal Gazitt, Mark F. Foecking, Robert Ortmann, Michael L. Misfeldt, Rebecca L. Jorgenson, Steven L. Young, Eric L. Greidinger	59
13	T Cell Immunity in Connective Tissue Disease Patients Targets the RNA Binding Domain of the U1-70kDa Small Nuclear Ribonucleoprotein 2002 ·The Journal of Immunology ·Eric L. Greidinger, Mark F. Foecking, (unknown), Craig W. Bailey, (unknown), David R. Lee, Robert W. Hoffman	34
14	T Cell Epitope Mapping of the Smith Antigen Reveals That Highly Conserved Smith Antigen Motifs Are the Dominant Target of T Cell Immunity in Systemic Lupus Erythematosus 2001 ·The Journal of Immunology ·(unknown), (unknown), Craig W. Bailey, David R. Lee, Robert W. Hoffman	27
15	T cell receptor ?-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease 1999 ·Arthritis & Rheumatism ·(unknown), (unknown), David R. Lee, Robert W. Hoffman	19
16	Cytokine mRNA Expression in the B/W Mouse Model of Systemic Lupus Erythematosus—Analyses of Strain, Gender, and Age Effects 1997 ·Clinical Immunology and Immunopathology ·Robert W. McMurray, Robert W. Hoffman, (unknown), Sara E. Walker	41
17	Analysis of anti–u1 RNA antibodies in patients with connective tissue disease 1995 ·Arthritis & Rheumatism ·Robert W. Hoffman, Gordon C. Sharp, Susan L. Deutscher	48
18	Molecular and Serologic Analysis of Hla Genes and Immunoglobulin Allotypes in Iga Nephropathy 1994 ·Autoimmunity ·Alan M. Luger, (unknown), Ruth Walker, Janardan P. Pandey, Robert W. Hoffman	12
19	Human autoantibodies against the 70‐kd polypeptide of u1 small nuclear rnp are associated with hla‐dr4 among connective tissue disease patients 1990 ·Arthritis & Rheumatism ·Robert W. Hoffman, (unknown), Yoshihiko Takeda, John E. Hewett, Ingvar Pettersson, Ulf Nyman, Alan M. Luger, Gordon C. Sharp	74
20	Specific targeting of human peripheral blood T cells by heteroaggregates containing anti-T3 crosslinked to anti-target cell antibodies. 1986 ·The Journal of Experimental Medicine ·Pilar Pérez, Robert W. Hoffman, J A Titus, David M. Segal	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact